ANIX MEXC RealStocks
Own real ANIX shares through MEXC's regulated brokerage partner.
Suitable for long-term holding.
- Own the actual shares
- Receive dividends and voting rights
- Buy fractional shares starting at $1
Last updated: 2026-11-19 06:55:20. Prices reflect the latest closing data and will resume updating on the next trading day. Stock price data is sourced from Massive.
Anixa Biosciences, Inc. (ANIX) operates in the PHARMACEUTICAL PREPARATIONS sector and is listed on NASDAQ. The stock is currently priced at $2.71, with a market capitalization of $92.82M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $2.32 to $5.46. This page covers its latest market performance, valuation, price trends and company information.
$92.82M | |
$2.70 | |
$2.82 | |
$2.62 | |
$2.67 | |
244.94K | |
280.79K | |
-- | |
$5.46 | |
$2.32 | |
-- | |
2026-07-31 |
Anixa Biosciences, Inc. (ANIX) last closed at $2.71 as of 2026-11-19 00:31:00, up 1.50% ($0.04) from the previous close of $2.67.
During the latest regular trading session, ANIX traded between $2.62 and $2.82, with a volume of 244.94K shares. The closing price was near the middle and near the lower end of its 52-week range.
Over the past seven days, Anixa Biosciences, Inc. (ANIX) moved from $3.06 to $2.71, representing a decline of 11.34% ($0.35).
The stock traded between $2.54 and $3.21 during the period. The latest price is near the lower end of the 7-day range, indicating strong downward.
The average daily volume was 232.72 thousand shares, up versus the previous seven-day period, indicating higher trading activity.
Position in Range: 12.5%
ANIX is currently trading at $2.71, placing it 12.5% of the way from its 52-week low of $2.32 to its 52-week high of $5.46. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
Anixa Biosciences Inc is a biotechnology company developing therapies and vaccines focused on critical unmet needs in oncology. Its operations are organized into reportable segments comprising Cancer Vaccines, CAR-T Therapies, and Other. The Cancer Vaccines segment involves vaccines to treat and prevent breast and ovarian cancer, as well as additional cancer vaccines targeting intractable cancers, including high-incidence malignancies in lung, colon, and prostate. The CAR-T Therapies segment involves the development of liraltagene autoleucel (lira-cel), an ovarian cancer immunotherapy using chimeric endocrine receptor-T cell technology, developed at its subsidiary, Certainty Therapeutics, Inc. The Other segment consists of legacy operations, including limited patent licensing activities.
| Industry | PHARMACEUTICAL PREPARATIONS |
| Employees | 4 |
| Exchange | NASDAQ |
| Company Website |
Eligible investors can buy real shares of Anixa Biosciences, Inc. (ANIX) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.
Stock prices and market data on this page, including price changes and market status, are provided by Massive and other third-party news and data platforms. Market data may be delayed and may differ from prices on other platforms or the prices at which trades are executed on MEXC. MEXC does not guarantee the accuracy, completeness, or timeliness of third-party data. MEXC offers trading products related to ANIX, including Stocks, Tokenized Stocks, and Stock Futures.
The stock price information displayed on this page is provided for reference purposes only and may be delayed or differ from real-time market data. Prices, charts, and related metrics do not constitute investment advice and should not be relied upon for trading or investment decisions. MEXC is not responsible for any losses incurred based on the stock price information provided on this page. Please refer to official market sources or consult licensed financial professionals before making any investment decisions.
Estimate the value between ANIX shares and USD.
ANIX Shares to USD
1.00 ANIX shares = 2.713 USD
Calculations are estimates based on the latest available price and are for reference only.